Atlas Trials

Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment

Clinical trial NCT07147101 · RECRUITING

Trial details

NCT number
NCT07147101
Sponsor
Fudan University
Status
RECRUITING
Study type
OBSERVATIONAL
Advanced Hepatocellular Carcinoma (HCC)
Start date
2025-09-01
Primary completion
2028-09-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.